Meridian Bioscience to Present at the H. C. Wainright 22nd Annual Global Investment Conference
August 31 2020 - 7:00AM
Meridian Bioscience, Inc. (NASDAQ: VIVO) announced today that Jack
Kenny, Chief Executive Officer, and Bryan Baldasare, Executive Vice
President and Chief Financial Officer, will present at the H. C.
Wainright 22nd Annual Global Investment Conference on Monday,
September 14, 2020 at 12:30pm ET.
To access the live webcast, go the Events &
Presentations section of the Company’s Investor Relations website
at https://investor.meridianbioscience.com/. Participants should
register several minutes in advance of the event’s start time by
following the link provided for the event.
About Meridian Bioscience,
Inc.Meridian is a fully integrated life science company
that develops, manufactures, markets and distributes a broad range
of innovative diagnostic products. We are dedicated to developing
and delivering better solutions that give answers with speed,
accuracy and simplicity that are redefining the possibilities of
life from discovery to diagnosis. Through discovery and
development, we provide critical life science raw materials used in
immunological and molecular tests for human, animal, plant, and
environmental applications. Through diagnosis, we provide
diagnostic solutions in areas including gastrointestinal and upper
respiratory infections and blood lead level testing. We build
relationships and provide solutions to hospitals, reference
laboratories, research centers, veterinary testing centers,
physician offices, diagnostics manufacturers, and biotech companies
in more than 70 countries around the world.
Meridian’s shares are traded on the NASDAQ
Global Select Market, symbol VIVO. Meridian’s website address is
www.meridianbioscience.com.
Contact:Charlie WoodVice
President – Investor RelationsMeridian Bioscience, Inc.Phone: +1
513.271.3700Email: mbi@meridianbioscience.com
Meridian Bioscience (NASDAQ:VIVO)
Historical Stock Chart
From Sep 2024 to Oct 2024
Meridian Bioscience (NASDAQ:VIVO)
Historical Stock Chart
From Oct 2023 to Oct 2024
Real-Time news about Meridian Bioscience Inc (NASDAQ): 0 recent articles
More News Articles